Nedfharm Consultancy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 30.13%
(FY 2022)
- Profit 49.29%
(FY 2022)
- Ebitda 40.19%
(FY 2022)
- Net Worth 43.35%
(FY 2022)
- Total Assets 31.50%
(FY 2022)
About Nedfharm Consultancy
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ganesh Bhat, Yeraguntlu Eswaramma, and Nethra Gowder serve as directors at the Company.
- CIN/LLPIN
U85100KA2018PTC116002
- Company No.
116002
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nedfharm Consultancy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Bhat  | Director | 04-Sep-2018 | Current |
| Yeraguntlu Eswaramma | Director | 16-Feb-2019 | Current |
| Nethra Gowder | Director | 04-Sep-2018 | Current |
Financial Performance of Nedfharm Consultancy.
Nedfharm Consultancy Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.13% increase. The company also saw a substantial improvement in profitability, with a 49.29% increase in profit. The company's net worth Soared by an impressive increase of 43.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nedfharm Consultancy?
In 2019, Nedfharm Consultancy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shirdi Pharmaceutical Consultancy Private LimitedActive 11 years 7 months
Ganesh Bhat and Yeraguntlu Eswaramma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nedfharm Consultancy?
Unlock and access historical data on people associated with Nedfharm Consultancy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nedfharm Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nedfharm Consultancy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
